Human Capital Benefits participates in Canadian Leadership Council on Drug Plan Partnerships

Chris Pryce of Human Capital Benefits was chosen to attend a council meeting with selected advisors/consultants, pharmacy and drug manufacturers to review presentations on evidence informed decision making through the Private payer lens, plan sponsor obligations and pharmacogenics.  There will be a report published for Benefits Canada in Summer 2021.

Insights

More Related Articles

Benefits Canada – 2026 Canadian Leadership Council on Drug Plan Partnerships

The here and now of pharmacogenetic testing

2025 Canadian Leadership Council on Drug Plan Partnerships